Senile Macular Degeneration

What is Yellow Spot Disease; The yellow spot is the visual cortex, which is located behind our eyes and where the vision function that we call the retina occurs and which is seen the most clearly in the net layer and there are yellow substances inside. All diseases that degenerate this center are called macular degeneration.

Symptoms of Yellow Spot Disease

A few of the macular degeneration start in childhood and adulthood, but the age-related macular degeneration that we see most often occurs with the age of 60s. The most common and earliest symptom is not being able to see clearly, but seeing the middle of the objects bent, crooked, and seeing the middle of what is being looked at is dark. Following this, the quality and power of vision decreases over time, and the patient cannot read the distant objects, and becomes unable to read books.

Why Does Yellow Spot Disease Happen?

The most common reason is the degeneration of the yellow spot area with the increasing age. Besides, high point myopia and some congenital retinal patients may also have macular degeneration.

Risk factors in Yellow Point Disease

The most important risk factor for yellow spot disease is age. The older you are, the higher the risk of encountering this disease. It is more common in women. Smoking, high cholesterol, hypertension, long-term exposure to sunlight and vitamin deficient diet are other risk factors. Inheritance is also important...

Can you explain the types of macular degeneration?

It is 2 types. 80% of it is dry type, that is, the type that does not have bleeding, fluid accumulation or newly formed veins. 20% of it is wet type and this type has fluid accumulation, bleeding and newly formed but harmful vascular network. Dry type is relatively harmless and may turn into wet type over time. There are pathologies that can impair vision to an advanced degree in 85% of the wet type. If left untreated, the wet type is a dangerous type with high permanent damage rate.

When should I see a doctor?

Firstly, regular eye control is required every year after the age of 40. However, if there are complaints of decreased vision and dark, oblique, crooked vision of the objects, an eye-retina specialist should be seen immediately. Early diagnosis is very important.

What happens if untreated?

If the macular degeneration is not added to another disease, it will not result in blindness. However, it can turn a person into a person who lives dependent on others and cannot see the half-meter front. This significantly lowers the quality of life and takes the person away from all social life.

What is the frequency of the disease?

There is a prevalence of 30% after the age of 60, 40% after the age of 70, 50% after the age of 80 and 70% after the age of 90.

How is the macular degeneration treated?

The main treatment known for the wet type is intraocular drug injections that prevent newly formed harmful vascular development. There is no cure for dry type, but there are special vitamins for protective purposes.

Are there any new developments that can be used to increase vision in dry type macular degeneration?

Vitamins containing lutein are used for dry type macular degeneration. Apart from this, an intraocular lens has been developed that can be applied to increase the vision level. This intraocular lens application, called Eyemax-mono, increases the visual level by shifting the dark areas formed in the visual field from the center to the periphery in dry-type macular patients. This intraocular lens works like a small telescope, enhancing the vision by slightly enlarging the image and shifting the image to the sound areas of the retina, increasing the vision level. The healthy retina assumes the role of the visual cortex, called the macula, and provides a better central vision. This increased central vision increases the chances of daily activities such as driving, selecting faces and reading. Eyemax-mono application is a short-term operation and does not require hospitalization.

Is Eyemax-mono used in eye diseases beside dry type macular degeneration?

Wet-type macular degeneration that has been stably or actively treated

Diabetic (blood glucose-dependent) retinal disease that has been treated stably or actively

Retinal disease due to high myopia

Macular hole / Epiretinal membrane

In which conditions is Eyemax mono not applied?


Untreated active wet type macular degeneration

Untreated active diabetic retinopathy disease

For Eyemax-mono application, vision levels must be within a certain range. In dry type macular degeneration, the size of the damaged area in the retina must be below a certain value. Consequently, it is necessary to decide whether the patients are suitable for examination or not before applying intraocular lenses.

Is there any other lens application in dry type macular degeneration for patients who have previously had lens implantation due to cataract operation?

Macrovision therapy

Vision increase can be achieved in patients with macular degeneration through a specially designed dual-focus intraocular lens with a central optical field providing + 10.0D insertion power. Thanks to this operation, it can be easily applied with the lens structure that can be placed on the existing lens in patients who have had cataract surgery and with intraocular lenses.

To whom is macrovision treatment recommended?

It only targets patients with advanced dry-type macular degeneration, who have an intraocular lens attached, and offers a convenient, simple and safe solution to treat their distorted close vision due to macular degeneration.

Macrovision focuses on advanced SMD patients, but it may also be useful for patients with other macular diseases, for example myopic maculopathy, diabetic maculopathy or hereditary retinal diseases.

Two-thirds of patients with advanced SMD and visual acuity of 0.3 or less have already had intraocular lenses due to cataract surgery - these patients can benefit from macrovision.

The operation can be performed simultaneously with cataract operation, but preferably cataract surgery should be done first. After a repeated visual acuity test after surgery, macrovision therapy can be continued if the patient is still dissatisfied.